Precision cjc1295 DAC 5mg

CJC-1295 DAC 5 mg – Long-Acting Peptide Research Compound

CJC-1295 DAC 5 mg is a synthetic peptide research compound designed to interact with growth hormone–releasing hormone (GHRH) pathways in controlled laboratory settings. The DAC (Drug Affinity Complex) modification extends the peptide’s half-life, allowing for prolonged activity during research applications.

This compound is commonly studied for its role in growth hormone signaling dynamics, endocrine pathway modulation, and peptide longevity in experimental models.

Research Focus Areas

• Growth hormone–releasing hormone (GHRH) pathways
• Peptide half-life and sustained signaling models
• Endocrine and metabolic research applications
• Recovery, repair, and physiological signaling studies

Product Specifications

• Compound: CJC-1295 with DAC
• Strength: 5 mg
• Category: Peptide research compound
• Format: Lyophilized powder
• Intended Use: For laboratory and research purposes only

About This Compound

CJC-1295 DAC is distinguished by its extended activity profile due to the Drug Affinity Complex, making it a common choice in research protocols examining long-term peptide signaling compared to shorter-acting GHRH analogs. The 5 mg concentration supports accuracy and consistency in experimental measurement.

This product is not intended for human consumption and is not intended to diagnose, treat, cure, or prevent any disease.